| Name | Title | Contact Details |
|---|
Drager is an international leader in the fields of medical and safety technology. The family-owned company was founded in Lubeck, Germany, in 1889. The company`s long-term success is based on the four key strengths of its value-driven culture: customer intimacy, professional employees, continuous innovation and a commitment to outstanding quality. Drager offers its customers anaesthesia workstations, medical ventilation, patient monitoring as well as neonatal care for premature babies and newborns. With ceiling supply units, IT solutions for the OR, and gas management systems the company is at the customer`s side throughout the entire hospital. Emergency response services, law and regulatory enforcement and the industry trust in Drager`s integrated hazard management, in particular for personal protection and plant safety. This includes: respiratory protection equipment, stationary and portable gas detection systems, professional diving equipment and systems, as well as alcohol and drug impairment detection. In collaboration with its customers Dräger develops customized solutions, such as entire fire training systems, training concepts and workshops. Drager has more than 13.700 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
Kelcourt Plastics Inc is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prudental Laboratories Inc is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.